Monographie - Gemcitabine hydrochloride

Последно актуализиране :
03/05/2024

Gemcitabine hydrochloride

Химична структура

Търговско наименование

Търговските имена са примерни и съставът на помощните вещества може да бъде различен в зависимост от държавата и лабораториите

Accogem	Мексико
Antoril	Аржентина
Axigem	Германия
Bendacitabin	Германия
Binoptos	Мексико
Celzar	Перу
Dercin	Румъния
Dhacibine	Малайзия
Emcitab	Колумбия
Eriogem	Аржентина, Еквадор
Fotinex	Аржентина, Перу
Gebina	Аржентина
Gebitan	Колумбия
Gembio	Аржентина, Еквадор, Чили
Gemcimira	Перу, Чили
Gemcit	Португалия
Gemcitabin	Германия
Gemcitac	Чили
Gemko	Турция
Gemsibin	Турция
Gemsol	Австрия
Gemtero	Перу, Чили
Gemzar	Австралия, Австрия, Белгия, Бразилия, Великобритания, Венецуела, Германия, Гърция, Дания, Египет, Еквадор, Иран, Ирландия, Исландия, Испания, Италия, Канада, Колумбия, Люксенбург, Малайзия, Мароко, Мексико, нова Зеландия, Норвегия, Обединени арабски емирства, Полша, Португалия, Румъния, Словения, Съединени Американски щати / САЩ, Тайланд, Тунис, Турция, Унгария, Финландия, Франция, Холандия, Хърватия, Чили, Швейцария, Швеция, Южноафриканска република / ЮАР
Gentabin	Колумбия
Haxanit	Аржентина, Перу
Lenfotabin	Мексико

Библиография : Gemcitabine hydrochloride

	Вид	Публикация
1422	Списание	Xu QA, Zhang Y, Trissel LA. Physical and chemical stability of gemcitabine hydrochloride solutions. J Am Pharm Assoc 1999 ; 39: 509-513.
1423	Списание	Trissel LA, Martinez JF, Gilbert DL. Compatibility of gemcitabine hyrochloride with 107 selected drugs during simulated Y-site injection. J Am Pharm Assoc 1999 ; 39: 514-518.
1501	Списание	Beitz C, Bertsch T, Hannak D, Schrammel W, Einberger C, Wehling M. Compatibility of plastics with cytotoxic drug solutions - comparison of polyethylene with other container materials. Int J Pharm 1999 ; 185: 113-121.
1520	Лаборатория	Etude de stabilité des médicaments en Ecoflac® B Braun 2001
1611	Списание	Chalmers JR, Bobek MB, Militello MA. Visual compatibility of amiodarone hydrochloride injection with various intravenous drugs. Am J Health-Syst Pharm 2001 ; 58: 504-506.
1625	Списание	Trissel LA, Saenz C, Williams YW, Ingram D. Incompatibilities of lansoprazole injection with other drugs during simulated Y-site coadministration. Int J Pharm Compound 2001 ; 5: 314-321.
1662	Списание	Trissel LA, Saenz CA, Ingram DS, Ogundele AB. Compatibility screening of oxaliplatin during simulated Y-site administration with other drugs. J Oncol Pharm Practice 2002 ; 8: 33-37.
1663	Списание	Ponton JL, Munoz C, Rey M, Val M. The stability of (lyophilized) gemcitabine in 0.9% sodium chloride injection. EJHP 2002 ; 1: 23-25.
1925	Списание	Trissel LA , Williams KY, Gilbert DL. Compatibility screening of linezolid injection during simulated Y-site administration with other drugs and infusion solutions. J Am Pharm Assoc 2000 ; 40: 515-519.
1953	Списание	Trissel LA, Saenz CA, Ogundele AB, Ingram DS. Physical compatibility of pemetrexed disodium with other drugs during simulated Y-site administration. Am J Health-Syst Pharm 2004 ; 61: 2289-2293.
1982	Списание	Trissel LA, Ogundele AB. Compatibility of anidulafungin with other drugs during simulated Y-site administration. Am J Health-Syst Pharm 2005 ; 62: 834-837.
2009	Списание	Trissel LA, Zhang Y. Physical and chemical stability of palonosetron hydrochloride with fluorouracil and with gemcitabine hydrochloride during simulated Y-site administration. Int J Pharm Compound 2005 ; 2005, 9, 4: 320-322.
2262	Списание	Brammer MK, Chan P, Heatherly K, Trusley C, Kupiec TC, Trissel LA, Psathas PA, Gilmor T, Schaufelberger D. Compatibility of doripenem with other drugs during simulated Y-site administratioN Am J Health-Syst Pharm 2008 ; 65: 1261-1265.
2344	Лаборатория	Stabilité physico-chimique de la gamme oncologie Ebewe Pharma France après dilution. Ebewe Pharma 2009
3262	Списание	Manners S, Galettis P, de Souza P. Conditions causing gemcitabine crystallization. J Oncol Pharm Practice 2011 ; 17, 4: 395-399.
3496	Лаборатория	Gemcitabin Actavis solution - Stability Study Actavis 2009
3670	Списание	Sewell G, Massimini M. Studies on the stability and compatibility of cytotoxic drug infusion with the Tevadaptor system. EJOP 2014 ; 8, 3: 26-30.
4310	Списание	Mizuta N, Nakagawa T, Yamamoto K, Nishioka T, Kume M, Makimoto H, Yano I, Minami H, Hiral M. Compatibility and Stability of Nab-Paclitaxel in Combination with Other Drugs. Kaohsiung J Med Sci 2017 ; 63, 1: E9-E16.
4736	Списание	Closset M, Colsoul ML, Goderniaux N, Bihin B, Jamart J, Onorati S, Soumoy L, Hecq JD, Odou P, Galanti L. An Ultra-High-Performance Chromatography method to study the long term stability of gemcitabine in dose banding conditions. J Pharm Biomed Anal 2023

Mentions Légales